Web Analytics Made Easy - StatCounter

Everolimus Tablet Tenders

Get complete information related to latest Everolimus Tablet Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Everolimus Tablet Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Everolimus Tablet Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :42539792 Due date: 28 Jan, 202628 Jan, 2026 NA
Tender For corrigendum : supply of sch iii (supply of creams, drops, ointments, oral liquids, lotions, syrups, liniments, spiritious preparations & miscellaneous medicines etc.) - sch iii (supply of creams, drops, ointments, oral liquids, lotions, syrups, liniments, spiritious preparations & miscellaneous medicines etc.), eye drops containing chloramphenicol 0.5%, eye drops containing fluconazole 0.3%, eye drops containing gatifloxacin 0.3%, eye drops containing ketorolac 0.5%, eye drops containing natamycin 5%, eye drops containing pilocarpine 2%, eye drops containing phenylephrine hydrochloride u.s.p.10%, eye drops containing povidone iodine 5%, eye drops containing potasium iodide 3.3% with sodium chloride 0.83% with calcium chloride 1.3%, eye drops containing tropicamide 1%, eye drops containing homatropine 2%, eye ointment atropine sulphate 1% w/w, eye ointment containing acyclovir 3%, eye ointment containing neomycin sulphate 0.5% w/w, eye applicaps of 250 mg containing chloramphenicol 1% w/w, ear drops containing clotrimazole 1% & lignocaine hydrochloride 2% + gentamycin 0.3% beclomethasone 0.025%, ear drops containing beclomethasone 0.025% +chloramphenicol 1% + clotrimazole 1% + lignocaine 2%, eye/ear drops containing ciprofloxacin hydrochloride 0.3 %, ear/eye drops containing gentamycin sulphate 0.30%, eye/ear drops containing betamethasone salt 0.1% or dexamethasone salt 0.1% & neomycin sulphate 0.5 % w/v, eye/ear drops containing dexamethasone salt 0.1% or betamethasone salt 0.1%, antialergic nasal spray beclamethasone nasal spray 50 mcg/spray, salbutamol nebulising solution 5 mg/ml., lignocaine hydrochloride spray topical 10 % aerosol pump spray for anaesthesia of mucosa 10 mg/puff, cream containing clobetasone butyrate 0.05%, cream containing framycetin sulphate 1% w / w, cream containing silver sulphadiazine 1% (sterile), salicylic acid ip 6.0% w/w ointment base qs, salicylic acid ip 12% w/w ointment base qs, gel containing heparin for l.a 200 i.u/gm, lignocaine hydrochloride jelly 2% (sterile), sterilized non greasy all purpose lubricant jelly, tincture benzoin, lignocaine hydrochloride topical solution 4 % sterile.not for injection, rabeprazole sodium powder for oral suspension sodium bicarbonate as buffer containing rabeprazole ip 20mg, dry syrup containing artemether 40 mg and lumefantrine 240 mg in 5 ml, syrup containing amoxycillin 125mg/5ml, syrup containing chloroquine each 5 ml containing chloroquine phosphate ip 80 mg equivalent to 50mg of chloroquine base, syrup containing cloxacillin 125 mg/5ml, syrup containing codeine phosphate, syrup containing erythromycin 125 mg / 5 ml., syrup containing isoniazid 100 mg/5 ml. with/ without vit b6, syrup containing nitazoxanide 100mg/5ml, syrup containing nalidixic acid 300 mg./ 5 ml., syrup containing prednisolone 5 mg/5 ml. alchohol free, syrup containing phenobarbitone 20mg/5ml, syrup containing pyrazinamide 250mg/5ml, syrup containing rifampicin 100 mg/5 ml, elixir containing digoxin 50 mcg/ml least content of alchohol, suspension containing ibuprofen 100 mg/ 5ml, suspension containing trimethoprim 40 mg & sulphamethoxazole 200mg / 5 ml, oral suspension containing each 1ml of the reconstituted suspension contains oseltamivir phosphate ip equivalent to oseltamivir 12 mg, syrup tolu, caffeine citrate sterile oral solution containing caffeine base 20 mg/ml, human milk fortifier each sachet containing protein -min 0.2 g calories min 3 cal, calcium min 15 mg, phosphorus min 7.5 mg , vitamin d - 3 mcg min., multivitamin drops containing multivitamin, mulitimineral and lysine, feracrylum 1% w/w gel, solution containg ferycylum 1%w/v, ointment containing benzyl nicotinate 2 mg + heparin 50 iu for la, calcipotriol 0.005% w/w cream, permethrin (5% w/w) lotion/rinse, hydroxyzine hydrochloride 10mg/5ml, chlorhexidine gluconate sol 0.2% mouthwash, eberconazole cream 1% w/w,, polyethyelene glycol 400 ph. eur. - 0.4% w/v, propylene glycol ph.eur 0.3% w/v, hydroxypr

Central Government/Public Sector

CTN :43492303 Due date: 30 Jan, 202630 Jan, 2026 55.94 Crore
Tender For supply of essential drugs under sdl. - colistimethate sodium injection 1 million iu powder for solutionvial, faropenem tablet 200mg 1x6, polymixin b injection 500000 iuvial, tigecycline injection 50mgvial, teicoplanin injection 400mgvial, valganciclovir tablet 450 mg1x2, voriconazole tablet 200 mg 1x4, nicorandil tablet 10 mg1x10/1x20, isoprenaline injection 2mg1 ml amp, octreotide injection 100 mcg/ml1 ml amp, acetylsalicylic acid (a)+clopidogrel(b)tablet (a)150 mg+(b)75 mg1x10, reteplase injection 18 mg vial, rifaximine tablet 550mg1x10, empagliflozin tablet 10 mg1x10, linagliptine tablet 5mg1x10, sitagliptin capsule 50 mg1x7/1x10, recombinant growth hormone injection per iuvial/pfs, ranibizumab injection 10 mg/ml (2.3 mg/0.23 ml per vial)vial/amp, i.v fat emulsion infusion 20%100 ml bottle, human albumin infusion 20%100 ml bottle /bag, multi-electrolyte in 5% dextroseinfusion 500 ml ffs plastic bottle, recombinant factor viia injection 1mgvial, rurioctocog alfa pegol injection 500 iu.vial/pfs, eptacog alfa (activated recombinant coagulation factor viia) injection 1 mgvial/pfs, luspatercept injection 25 mg.vial, deferasirox tablet 400mg1x6/1x10, deferasirox tablet 100mg1x6/1x10, olanzapine tablet 10 mg1x10, quetiapine tablet 50mg1x10, gabapentin capsule 300 mg1x10, dutasteride soft gelatin capsule 0.5mg1x10, tamsulosin tablet 0.4mg mr1x10, silodosin tablet 8mg1x10, sevelamer tablet 400 mg 1x10, abiraterone aceteatetablet 250 mg120 tablets in a bottle, anti thymocyte globuline injection 250 mg.5 ml glass vial, azacitidine injection 100 mgvial, cisplatin injection 50mgvial, crizotinib capsule 250mg1x10, cytarabine injection 100mgvial, cytarabine injection 500mgvial, dasatinib tablet 50 mg60 tabs container, decitabine injection 30 mgvial, daratumumab injection 400 mg/20 ml vial, daratumumab + hyaluronidase injection 1,800 mg daratumumab and 30,000 units hyaluronidase per 15 ml (subcutaneous)single-dose vial., degarelix injection 80mgvial, enzalutamide capsule 40 mg 1x28, erlotinib tablet 150mg1x10, everolimus tablet 0.25 mg 1x10, ibrutinib capsule 140mg120 capsule in a bottle, ifosamide injection ifosamide 1 gm with mesna 200 mgcombi pack of 20 ml vial of ifosamide & 3x2 ml amps of mesna, each 2 ml amp contains 200 mg mesna., leucovorin injection 50mg/5 mlvial/ampoule, leuprolide injection 3.75mgvial, nilotinib tablet/capsule 150 mg1x7/1x14, nilotinib tablet/capsule 200mg1x7/1x14, paclitexal injection 260 mgvial, palbociclib tablet/capsule 75 mg1x7/1x21, palbociclib tablet/capsule 125 mg1x7/1x21, pazopanib tablet 400mg30 tablets in a bottle, ribociclib tablet 200 mg1x21, ruxolitinibtablet 20 mg1x10/1x14, sorafinibtab 200mg120 tablets in a bottle, sunitinib tablet/capsule 12.5mg1x7, bevacizumab injection 100mgvial, onasemnogene abeparvovec suspension for iv infusion 2.0 1013 vector genomes/mlvial, asciminib tablet 40 mg.30 tablets in a bottle, mepolizumab injection 100 mg vial, teclistamab injection 30 mg/3ml (10 mg/ml)vial, obinutuzumab injection 1,000 mg/40 ml (25 mg/ml) vial, polatuzumab vedotin injection 140 mg/vial.vial, atezolizumab injection 1,200 mg/20 ml (60 mg/ml) vial, spesolimab injection 450 mg/7.5 ml (60 mg/ml) vial, pembrolizumab injection 100 mg/4 ml (25 mg/ml)vial, ocrelizumab injection 300 mg/10 mlvial, ustekinumab injection 130 mg/26 ml (5 mg/ml)vial, benralizumab injection 30 mg/1 mlpfs, faricimab injection 6 mg/0.05 ml (120 mg/ml)vial, acalabrutinib capsule 100 mg30 capsule in a bottle, inotuzumab ozogamicin injection 1 mg/vialvial, buprenorphine (a) + naloxone (b)tablet (sub-lingual) 2 mg (a) + 0.5 mg (b)1x10, etanercept injection 25 mgpfs/vial, etanercept injection 50 mgpfs/vial, alirocumab injection 75 mg/ml.pfs, evolocumab injection 140 mg/ml.pfs, inclisiran injection 284 mg/1.5 ml.pfs, risdiplam tablet 5 mg30 tablets in a bottle, risdiplam powder for oral solution 0.75 mg/ml after reconstitution.80 ml bottle, fulvestrant injection 250 mgvial/pfs, recombinant human interferon beta-1a injection 30 mcg

CTN :43205173 Due date: 12 Jan, 202612 Jan, 2026 2.88 Lacs
Tender For corrigendum : feracrylum 1 percent w/w gel (1 x 15gm) - e-quotation for purchase of feracrylum 1%w/w gel (1 x 15gm)
 Loading, Please wait...

Connect us via What's Up